» Articles » PMID: 28342928

Does Implementing an Enhanced Recovery After Surgery Protocol Increase Hospital Charges? Comparisons From a Radical Cystectomy Program at a Specialty Cancer Center

Overview
Journal Urology
Specialty Urology
Date 2017 Mar 27
PMID 28342928
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare perioperative charges induced at the initial phase of a standardized enhanced recovery after surgery (ERAS) program from a tertiary referral center.

Methods: A multidisciplinary ERAS protocol was implemented in our department on July 2015. During the subsequent year, all patients were treated according to this protocol (ERAS group). The patients were compared in terms of real in-hospital charges per surgical episode with a control group consisting of consecutive patients before the start of ERAS. Individual charges were analyzed per sample population and compared with the Wilcoxon rank-sum test or t test. Additionally, cost variances for each group were evaluated.

Results: A total of 257 consecutive patients were evaluated of which the last 112 were ERAS patients. The median length of stay for each group was 6 days (P = .748). ERAS patients incurred higher medication charges ($1939 vs $1729, P = .036). Control patients incurred higher supplies ($861 vs $692), treatment ($90 vs $72), and miscellaneous charges ($537 vs $388) (all, P < .001). The median total charges per patient were $59,539 for the control group and $60,655 for the ERAS group (P = .175). ERAS adoption significantly reduced variance in billed charges (P < .001).

Conclusion: ERAS implementation did not significantly increase expenditure for cystectomy patients. ERAS showed decreased variance in charges likely due to standardization of care while eliciting savings in supplies, treatment, and miscellaneous costs.

Citing Articles

Cost of Care in Open Cystectomy Patients Across Time and Space: Does it matter?.

Sun H, Prunty M, Isali I, Mahran A, Ginsburg K, Markt S Bladder Cancer. 2024; 7(4):439-447.

PMID: 38993992 PMC: 11181807. DOI: 10.3233/BLC-211580.


Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature.

Joyce D, Sharma V, Williams S Pharmacoeconomics. 2023; 41(7):751-769.

PMID: 37088844 DOI: 10.1007/s40273-023-01273-8.


Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient's undergoing urologic oncology surgery: a systematic review.

Brooks N, Kokorovic A, McGrath J, Kassouf W, Collins J, Black P World J Urol. 2020; 40(6):1325-1342.

PMID: 32648071 DOI: 10.1007/s00345-020-03341-6.


Enhanced REVENUE After Surgery? A Cost-Standardized Enhanced Recovery Pathway for Mastectomy Decreases Length of Stay.

Ackerman R, Hirschi M, Alford B, Evans T, Kiluk J, Patel S World J Surg. 2018; 43(3):839-845.

PMID: 30456482 DOI: 10.1007/s00268-018-4850-0.


An Update in Enhanced Recovery Following Radical Cystectomy.

Ghodoussipour S, Djaladat H Curr Urol Rep. 2018; 19(12):98.

PMID: 30338450 DOI: 10.1007/s11934-018-0855-3.